Evaluation of Chitosan as a Cell Scaffolding Material for Cartilage Tissue Engineering by Nettles, Dana Lynn
Mississippi State University 
Scholars Junction 
Theses and Dissertations Theses and Dissertations 
12-14-2001 
Evaluation of Chitosan as a Cell Scaffolding Material for Cartilage 
Tissue Engineering 
Dana Lynn Nettles 
Follow this and additional works at: https://scholarsjunction.msstate.edu/td 
Recommended Citation 
Nettles, Dana Lynn, "Evaluation of Chitosan as a Cell Scaffolding Material for Cartilage Tissue 
Engineering" (2001). Theses and Dissertations. 2006. 
https://scholarsjunction.msstate.edu/td/2006 
This Graduate Thesis - Open Access is brought to you for free and open access by the Theses and Dissertations at 
Scholars Junction. It has been accepted for inclusion in Theses and Dissertations by an authorized administrator of 
Scholars Junction. For more information, please contact scholcomm@msstate.libanswers.com. 
 
 
EVALUATION OF CHITOSAN AS A CELL SCAFFOLDING MATERIAL FOR 











Submitted to the Faculty of 
Mississippi State University 
in Partial Fulfillment of the Requirements 
for the Degree of Master of Science 
in Biomedical Engineering 




Mississippi State, Mississippi 
 
December 2001 
EVALUATION OF CHITOSAN AS A CELL SCAFFOLDING MATERIAL FOR 










Steven H. Elder Jerome A. Gilbert 
Assistant Professor of Biological Engineering Department Head of Agricultural and   
(Director of Thesis) Biological Engineering 





Ronald M. McLaughlin DVM, DVSC, Joel D. Bumgardner 
Dipl. ACVS Associate Professor of Biological 
Associate Professor and  Engineering 
Chief, Small Animal Surgery (Committee Member) 






Robin Wiser A. Wayne Bennett 
Research Chemist (polymers) Dean 
Sensor Research and Development Corp.  College of Engineering 
(Committee Member) 
 
Name: Dana Lynn Nettles 
 
Date of Degree: December 14, 2001 
 
Institution: Mississippi State University 
 
Major Field: Biomedical Engineering 
 
Major Professor: Dr. Steven H. Elder 
 
Title of Study: EVALUATION OF CHITOSAN AS A CELL SCAFFOLDING  
MATERIAL FOR CARTILAGE TISSUE ENGINEERING 
 
Pages in Study: 55 
 
Candidate for Degree of Master of Science 
 
 
Current articular cartilage tissue engineering endeavors, using synthetic polymers 
as scaffolds, have been somewhat successful.  However, the use of these materials has 
not yielded a satisfactory, functional replacement for articular cartilage.  Therefore, this 
project focuses on an alternative to these materials, chitosan, which is a naturally 
occurring biopolymer. 
The first project objective was to fabricate and analyze bulk, porous chitosan 
scaffolds, based on total porosity, average pore diameter, mechanical integrity, and 
degradation susceptibility.  Secondly, scaffolds were evaluated in terms of their ability to 
support neochondrogenesis, including assessments of cell attachment and viability, cell 
morphology, and the biosynthesis of proteoglycan and type-II collagen-rich extracellular 
matrix.   
Results indicated that chitosan scaffolds possessing an interconnecting, porous 
structure could be easily created through a simple freezing and lyophilization process, 
and these scaffolds did support neochondrogenesis.  Results suggest chitosan may be a 
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INTRODUCTION AND REVIEW OF LITERATURE 
 
 
 Tissue and organ failure accounts for nearly one half of the total annual healthcare 
expenditure in the United States, or approximately $400 billion (Lewis, 1995).  Injury 
and disease can affect something as simple as skin or can affect the more complex organs 
like the kidneys, liver, or heart.  Treatment options for these diseases and injuries include 
transplants, surgical repair, prosthetic devices, mechanical support, and in some cases, 
drug therapy; however, these treatments often provide unsatisfactory repair or 
maintenance.  In the case of transplantation, there are donor shortages and problems with 
immunosuppression.  Though the probability of rejection declines with each passing 
month following a transplant, the possibility persists throughout the patient’s life.  In the 
case of surgery, repairs are often imperfect and require follow-up procedures.  Prosthetic 
and mechanical support devices do not replace the full and proper function of the 
damaged tissue or organ, which often leads to continued disease progression.  Drug 
therapy is only available for some diseases, and can be associated with unwanted side 
effects such as heart rate and blood pressure fluctuations or nausea and loss of appetite 
for example.  Because these options do not provide satisfactory restoration of organ 
and/or tissue function, other avenues to restore, repair, and/or maintain tissues and organs 




 "Tissue engineering is the application of principles and methods of engineering 
and life sciences toward fundamental understanding of structure-function relationships in 
normal and pathological mammalian tissues and the development of biological substitutes 
to restore, maintain, or improve tissue functions" (NSF Workshop on Tissue Engineering, 
1988).  In other words, tissue engineering involves the use of cells and extracellular 
components, either synthetic or natural, to create replacement, implantable parts to 
restore, maintain, or repair the function of damaged/diseased tissues and organs (Nerem, 
1991).  This approach may be applied toward several goals.  Among these goals are 
providing replacement parts or cellular prostheses for the human body, providing vehicles 
to deliver engineered cells to an organism, creating tissue models with cells to study the 
states of diseases using aberrant cells, surfacing non-biological apparatuses, and 
providing acellular parts capable of regenerating tissues.   
The first important phase of any tissue engineering endeavor is to evaluate the 
types, ratios, and organization of the cells necessary to produce the tissue or organ of 
interest.  In general, one chooses a substrate material upon which to culture the cells that 
will enhance their organization in three dimensions and possibly provide initial 
mechanical integrity to the cell-polymer construct.  This material should be 
biocompatible, sterilizable, and have a large surface area on which new tissue can grow 
(Paige and Vacanti, 1995).  Applications may also require the scaffold material to be 
biodegradable.  Secondly, the cells of the tissue or organ of interest are seeded onto the 
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substrate and cultured for a period of time in vitro.  Finally, the cell-substrate construct 
may be implanted at the site of tissue damage. in vivo.   
This general approach is currently being used in many tissue engineering research 
labs around the world and has proven clinically successful, as evidenced by commercially 
available tissue engineered skins.  Other engineered tissues and organs such as cartilage, 
heart valves, blood vessels, bone, intestine, and tendon, among many others, also have 
promise for clinical success.  Obviously the more complex the tissue or organ, the more 
complex the engineering process, but the same general methods are still employed.  One 
tissue that is very well suited for tissue engineering methods is articular cartilage because 
of its fairly simple composition, one cell type, and lack of vascularity. 
 
Articular Cartilage 
Articular cartilage of the knee is a highly specialized connective tissue 
responsible for cushioning and lubricating.  It is avasular, aneural, alymphatic, is 
composed mostly of water, and contains only one cell type, the chondrocyte.  Articular 
cartilage has four distinct zones or areas.  The first is called the superficial zone, which is 
the thinnest zone and forms the gliding surface of the joint.  The second zone, the 
transition zone, lies just beneath the superficial zone and is a much more voluminous 
zone than the superficial zone.  The third zone is called the deep or radial zone.  This 
zone occupies the largest part of articular cartilage.  The last zone, the zone of calcified 
cartilage, lies just above the subchondral bone and acts to separate the softer cartilage of 
the radial zone from the hard bone beneath.  The zones are oriented in such a way to 
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compensate for different forces at the surface in relation to forces deeper in the tissue.  
Thus, the variation in the morphology of the zones reflects their structural role in 
withstanding the different forces within the joint.   
The dry weight cartilage as a whole is composed of chondrocytes and the 
extracellular matrix (ECM) they synthesize.  This extracellular matrix contains cartilage-
specific proteoglycans, type II collagen, and other noncollagenous proteins, whose 
purpose is to provide the overall cushioning and lubricating properties of articular 
cartilage (Buckwalter, 1983). 
The proteoglycans found in the ECM consist of a protein core composed of three 
regions and are responsible for the resiliency and stiffness to compression of articular 
cartilage.  The three regions of the core protein include a hyaluronic acid binding region, 
a keratin sulfate-rich region, and a chondroitin sulfate-rich region.  Hyaluronic acid, 
keratin sulfate, and chondroitin sulfate are glycosaminogylcans, which are repeating 
disaccharide units usually containing glucosamine or galactosamine and hexuronic acid 
or galactose.  Proteoglycans either exist as monomers, one unit (Figure 1A), or 
aggregates, which are groups of monomers connected via link proteins to a hyaluronic 





























Figure 1A.  Proteoglycan Monomer.  B.  Proteoglycan Aggregate 
 
Type II collagen provides the form and tensile strength of cartilage.  Collagen, in 
general, is composed of three alpha chains consisting of about 1000 amino acids each.  
The three alpha chains are tight left-handed helices that are bound together in a right-
handed helix to form what is called tropocollagen.  The spontaneous, but specific 
association of these tropocollagen molecules in the extracellular matrix of cartilage forms 
collagen microfibrils.  Type II collagen can be distinguished from other types of collagen 
by its high hydroxylysine content, the high content of carbohydrates bound to the 
hydroxylysine, and its small diameter fibrils (Buckwalter, 1983). 
Articular cartilage is particularly vulnerable to injury by trauma, disease, or 
congenital abnormalities.  Because cartilage is avascular, alypmhatic, and aneural 
(Buckwalter, 1983, Huber et al, 2000), disease and injury often go undetected until severe 
damage has already occurred (Buckwalter, 1983).  Once the tissue is damaged, it has 
little capacity for intrinsic repair.  Repair that does occur often results in 
fibrocartilaginous areas at the injury site consisting of clumps of cells bound together by 
sheets of collagen that do not exhibit the structural organization or strength for healthy 
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articular cartilage function (Huber, 2000, Buckwalter, 1983).  For this reason, disease 
often progresses to severe degenerative osteoarthritis.  Osteoarthritis affects an estimated 
20.7 million Americans and accounts for over $67 million in lost wages and productivity 
annually. 
Articular Cartilage Tissue Engineering 
Articular cartilage is a good candidate tissue for tissue engineering.  Its lack of 
vasculature and its single cell type allow the engineer to create a construct consisting 
simply of polymer and chondrocytes.  Chondrocytes are easily obtained from native 
cartilage, preferably from a young source, through a simple enzymatic digestion 
procedure.  These cells are considered primary cells and already possess the chondrocyte 
phenotype.  Chondrocytes also proliferate rapidly in monolayer, which allows the 
polymer substrate to be covered in a relatively short time period.  Another attractive 
quality of articular cartilage is that chondrocyte metabolism in vivo is anaerobic, using 
the glycolitic pathway, which is the usual mechanism of cell metabolism in vitro (Muir, 
1995; Lane et al, 1977); therefore, culture conditions do not create metabolic stresses on 
the chondrocytes.  
Mesenchymal stem cells (MSC’s) may also be used to engineer articular cartialge.  
Mesenchymal stem cells have the potential to become one of many different types of 
cells, including muscle, fat, bone, cartilage, tendon, and marrow stroma.  The exact 
environment needed for MSC’s to differentiate into each different cell type is not well 
understood, but includes varying combinations of nutrients, growth factors, spatial 
organization, and mechanical stimulus (Pittenger et al, 1999).   
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Once the type of cell to be used has been chosen, the next most important decision 
becomes the choice of the polymer substrate material.  The most extensively investigated 
materials for this application are the synthetic polymers poly(glycolic acid) (PGA), 
poly(L-lactic acid) (PLLA), and copolymers of the two, poly(DL-lactic-co-glycolic acid) 
(PLGA) (Freed et al., 1993; Sittinger et al., 1996; Baker and Goodwin, 1997; Grande et 
al., 1997).  Using these polymers, neocartilage has been engineered that resembles native 
cartilage in morphology and composition; however, there have been no reports of tissue 
engineered cartilage that meet the functional requirement to replace native cartilage 
(Dounchis et al., 2000; Chu et al., 1995).  Therefore, alternative polymers are currently 
being investigated, including the natural polymers collagen and hyaluronic acid 
(Hutmacher, 2000, Vaissiere et al 1999, Chevallay and Herbage, 1999).  These are very 
attractive materials because they are major constituents of the extracellular matrix of 
native articular cartilage and have been implicated in important cell signaling events that 
occur during chondrogenesis (Allemann et al., 2001).  Another attractive material is 
chitosan, a derivative of a naturally occurring biopolymer, whose chemical structure 
resembles that of hyaluronic acid.  Chitosan has been suggested as a bipolymer for use in 




Chitosan is a modified carbohydrate polymer derived from chitin, a structural, 
linear polysaccharide found in the exoskeletons of crustaceans.  Chitin is the second most 
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abundant biopolymer found in nature, second only to cellulose, and is an abundant waste 
product of the seafood industry.  It accounts for approximately one third of the dry weight 
of the waste shells.  Chitin can be easily processed into chitosan, typically by an initial 
decalcification in dilute, aqueous hydrochloric acid solution, and then deproteination in 
dilute aqueous sodium hydroxide.  The product is subsequently decolorized in 0.5% 
potassium permanganate (aqueous) and oxalic acid (aqueous) or sunshine, and finally 
deacetylated in hot, concentrated (40-50%) sodium hydroxide solution to produce the 
final product, chitosan.  Chitosans are a family of poly-D-glucosamine units that vary in 
their degree of deacetylation and molecular weight.   
There are two broad categories to explain chitosan.  It is either a random-type 
copolymer of GlcNAc and D-glucosamine termed heterogeneous chitosan, or it is 
sequenced blocks of acetylated glucosamines termed homogeneous chitosan (Aiba, 
1993).  These chitosans not only have different physical forms, but they can also act quite 
differently under certain environmental conditions. 
Both types of chitosans have been shown to possess characteristics that make 
them suitable as a tissue engineering cell substrate.  Certain chitosans are antimicrobial, 
biocompatible, and degrade to absorbable oligosaccharides (Denuziere, 1998).  Chitosan 
can be easily processed into porous scaffolds, films, and beads (Jarry et al, 2001).  
Especially important for cartilage tissue engineering, is that chitosan is polycationic, and 
its structure is similar to hyaluronic acid, an important molecule in the extracellular 
matrix of articular cartilage (Suh et al, 2000).  Two-dimensional substrates of chitosan 
have been shown to support the synthesis of cartilaginous extracellular matrix 
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components in monolayer culture (Lahiji et al, 2000), and have been shown to enhance 
osteogenesis in vitro (Klokkevold et al, 1996).   
 
Antimicrobial Action of Chitosan 
Some chitosans have been shown to have antimicrobial and bacteriostatic 
potential.  These chitosans inhibit microbial activity by attacking the microbial cell wall.  
Chitosan has been observed to act more quickly on fungi and algae than on bacteria 
(Cuero, 1999); however, like other properties of chitosan, this activity may be dependent 
on the type of chitosan, chitosan molecular weight, and degree of deacetylation, among 
other factors influencing the environment in which the chitosan is placed.  This 
antimicrobial activity of chitosan has been investigated for use as an anti-spoilage 
mechanism in food research.  Davydova et al (1999) found mildy hydrolyzed chitosan to 
exhibited antimicrobial activity against spoilage organisms.  Chitosan has also been 
investigated in medical applications as a possible mechanism to prevent secondary 
infections or to avert immunological rejections of implants and/or transplants.  Felt et al 
(2000) studied the antibacterial effects of chitosan against E. coli and S. aureus, in a study 
on the efficacy of using chitosan as a tear substitute in cases of dry eye to prevent 
secondary infections.  They found that the minimal inhibitory concentration of chitosan 
against E. coli was as low as 0.375 mg/ml and as low as 0.15 mg/ml against S. aureus 
(Felt et al, 2000).  In another study by Rhoades et al (2000) the interactions of bacterial 
endotoxins, lipopolysaccharide (LPS) and lipopolysaccharide-protein complex (LPPC), 
with chitosan were investigated.  These endotoxins are a major component of the outer 
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membranes of gram-negative bacteria.  The interaction between these endotoxins and 
chitosan was determined to be quite complicated and depended not only on the molecular 
organization of the endotoxin, but also on the degree of polymerization of the chitosan, 
with the highest affinity being between longer O-chain endotoxins and lower molecular 
weight chitosans.  They concluded this binding between chitosans and LPS decreased 
acute toxicity (Rhoades et al, 2000).  
 
Biodegradation of Chitosan 
 An important consideration in cartilage tissue engineering applications is the rate 
at which the polymer matrix used to organize the cells in vitro biodegrades, if at all.  The 
presence of non-biodegradable foreign materials in soft tissue often causes acute foreign-
body reactions elicited by the body’s immune system that can result in severe 
inflammation and soreness around the implant site.  However, while biocompatible, 
biodegradable polymers may elicit an initial immune response, it is often possible to 
control their degradation rate to decrease the length of time during which foreign material 
is in contact with living tissue.   
 Many studies have shown that chitin and chitosan are biodegradable polymers, 
and that they degrade in vivo mainly through their susceptibility to enzymatic hydrolysis 
mediated by lysozyme, which is ubiquitous in the human body; however, this action has 
been determined to be dependent on factors including pH, type of chitin or chitosan, and 
chitosan preparation method.  Davies et al (1969) determined that chitosan is most 
susceptible to hydrolysis by lysozyme at pH 5.2, and the optimum range of pH values has 
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been determined to be between pH 5.2 and 8.0 (Davies et al, 1969 and Shigemasa et al 
1993).   
Pangburn et al. (1982) studied the effect of deacetylation on the susceptibilities of 
chitin and chitosan to lysozyme and concluded that pure chitin (0% deacetylation) is most 
susceptible to lysozyme, while pure chitosan (100% deacetylation) cannot be degraded by 
lysozyme.  In 1990, Sashiwa et al. (1990) studied the relative rates of degradation of six 
chitosans varying in degree of deacetylation (45%, 66%, 70%, 84%, 91%, and 95%), but 
and found that 70% deacetylated chitosan degraded most quickly.   
Shigemasa et al. (1993) investigated the effects preparation methods had on 
degradation.  They found that for the same molecular weight and degree of deacetylation, 
homogeneously prepared chitosans were more susceptible to hydrolysis by lysozyme than 
heterogeneously prepared chitosans (Shigemasa et al, 1993).  These data were consistent 
with results from Lee et al. (1995).  Their findings suggest that there must be segments 
consisting of at least three consecutive N-acetyl sugar residues for lysozyme to be 
effective.  Block segments of N-acetyl sugars are commonly found in homogeneous 
chitosans.  Segments consisting of only glucosamine were not susceptible to hydrolysis 
by lysozyme (Lee, 1995).   
In a more recent study Varum et al. (1996) noted that the specificity for most 
enzymatically catalyzed reactions usually included the number of sugar residues 
recognized by the active site of the enzyme, and found that this was in fact true for the 
lysozyme-chitosan enzyme-substrate complex as well.  The lysozyme active cleft consists 
of six subsites, AL – FL.  They found a high affinity of the DL and EL subsites of the 
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active cleft of the lysozyme for A-units of chitosan (oligosaccharides with acetylated 
reducing ends) rather than D-units (oligosaccharides with deacetylated reducing ends).  
The FL subsite showed no selectivity for A- or D-units.  Their results also suggested that 
the nearest neighbor to the A-unit in the DL subsite should also be an A-unit for 
hydrolysis to occur at an appreciable rate (Varum et al., 1996).  Figure 2 depicts the 
lysozyme-chitosan complex and shows the specificity of these lysozyme subsites for 

























aLysoyme Binding Cleft  
Subsites (AL – FL) 
a 
a 
Figure 2. Schematic Illustration of Lysozyme Binding Cleft Subsites and Their 
Specificity for a- and /or d-units of the Chitosan Chain.  The Arrow 




While there is still conflicting data as to the exact products of chitosan 
degradation in vivo, the products have been identified as simple oligosaccharides that are 
not harmful and are often further degraded by -glucosaminidases before being easily 
flushed from the body (Onishi and Machida, 1999).  These oligosaccharides are usually 
tetramers, pentamers, and hexamers, which suggests that lysozyme acts as an endozyme.  
If chitosan were acting as an exozyme, oligomers resulting from enzymatic degradation 
would include the monomers and dimers of D-glucose.  
 
Chitosan Biocompatibility and Charge  
Tomihata and Ikada (1997) studied how degradation rate related to 
biocompatibility of chitosan films.  Results showed a marked decrease in the degradation 
of deacetylated films when the degree of deacetylation increased from 69% to 73%.  The 
more rapidly degrading 69% deacetylated chitosan showed strong cell adhesion 
properties, but elicited an acute inflammation reaction when implanted subcutaneously in 
rats.  This was most likely due to the accumulation of degradation products at the implant 
site, caused by rapid degradation of this film.  On the other hand, implanted films of 73% 
deacetylation or more did not elicit a strong foreign-body reaction, but still displayed 
very strong cell adhesion properties.  While cell adhesion properties of chitosan are 
attributed in part to its cationicity, other implantable materials with a positive charge 
often elicit acute foreign-body reactions in vivo.  Tomihata and Ikada believe the lack of 
severe reaction to more highly deacetylated chitosan was related to the zeta potential of 
these films.  Zeta potential is a measure of the potential at the boundary between a 
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particle and a continuous layer, or slipping plane.  More highly deacetylated chitosans, 
while still possessing a strong cationic charge due to their primary amines, display lower 
zeta potentials than their less highly deacetylated counterparts.  The lower zeta potential 
of more highly deacetylated chitosans in concert with their slower degradation are 
believed responsible for the lack of an acute inflammation reaction at the implant site 
(Tomihata and Ikada, 1997).  
  
Cellular and Tissue Responses to Chitosan  
 Chitosan’s cationic nature appears to be the main mechanism by which cells are 
attracted to this polymer; however, the degree of cell attachment has also been shown to 
be related to the percent deacetylation of the chitosan.  Prasitsilp et al (2000) studied how 
degree of deacetylation affected in vitro cellular responses to chitosan from two different 
sources, shrimp and cuttle fish.  They tested four chitosan substrates, two from each 
source, differing by about 10% in deacetylation and ranging between 76% and 90% 
deacetylation.  Results indicated that cells more readily attached to more highly 
deacetylated chitosans from both sources.  Their results also indicate that adherence and 
growth of cells cultured in extract mediums from the more highly deacetylated chitosans 
was greater than that of cells cultured in extract mediums from lesser deacetylated 
chitosans.  When cultured in the presence of discs made from the four different 
substrates, cells readily attached to and grew on discs of higher deacetylation while 
forming a ring around discs of lesser deacetylation; however, cells in the presence of 
discs of lesser deacetylation eventually began to migrate onto the discs when cultures 
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were allowed to become overgrown (Prasitslip et al, 2000).  This suggested the lack of an 
inhibition zone around the chitosan, which indicated that the chitosan was not cytotoxic.   
The in vivo chitosan-tissue biocompatibility studies tend to be in agreement with 
the in vitro cell response studies.  In vivo studies of tissue response to films of chitosan by 
Tomihata et al (1997) showed a marked increase in chitosan-tissue biocompatibility as 
chitosan deacetylation increased (Tomihada and Ikada, 1997).  Hidaka et al. (1999) 
studied the histopathological and immunohistochemical effects of chitosan membranes 
differing in degree of deacetylation implanted over rat calvaria.  Their findings suggested 
that chitosan membranes with percentages of deacetylation ranging between 65% and 
80% enhanced osteogenesis at the site of implantation, while those membranes of 94% or 
100% deacetylation showed only minimal osteogenesis; however, membranes of lesser 
deacetylation elicited a more marked inflammation response than membranes of higher 
deacetylation.  Hidaka et al suggested the need to control the inflammation response 
before chitosan could be considered in clinical applications (Hidaka et al, 1999).   
 Muzzarelli et al (1988) studied the biological activity of chitosan from an 
ultrastructural standpoint by investigating tissue repair induced by chitosan.  They used 
86.8% deacetylated chitosan in direct contact with or in substitution of dura mater, a 
tough, fibrous tissue found in the brain and spinal cord.  Results indicated that chitosan 
seemed to mimic the function of the dura mater and had a significant inductive and 
stimulatory effect on the rebuilding of this connective tissue.  Muzzarelli et al suggested 
that chitosan may be considered as a structural biomaterial for the repair of connective 
tissues because of its structural similarity to glycosaminoglycans found in the matrix of 
  
 16
these tissues (Muzzarelli et al, 1988).  Others have proposed using chitosan in substrates 
used to treat burns and other severe skin lesions.  These research teams have found that 
areas treated with substrates incorporating chitosan demonstrated an early return to 
normal skin color, facilitated rapid wound epithelializaiton and regeneration of nerves 
within the vascular dermis (Stone et al, 2000), and promoted skin with morphological 
equivalence to normal skin (Shahabeddin et al, 1990).  After their first clinical uses of a 
dermal substrate incorporating chitosan, Damour et al believed chitosan was a promising 
candidate as an alternative to a skin homograft because of its availability and its 
exemption from micro-organism transmission (Damour et al, 1994). 
 Chitosan has also been shown to have great potential to enhance osteogenesis 
when used as a film or two-dimensional culture substrate.  In a study to evaluate the 
effect of chitosan on osteoblast differentiation and bone formation in vitro, Klokkevold et 
al (1996) cultured mesenchymal stem cells from fetal Swiss Webster mice calvariae in 
the presence of 200 l of a 2mg/ml chitosan/acetic acid solution or in control wells that 
were either untreated or treated only with 0.2% acetic acid.  Results indicated a 
significantly higher number of osteoblast colonies in chitosan-treated wells as compared 
to control wells, while bone formation was also higher, but not statistically significant in 
the chitosan treated wells.  These results suggested that chitosan did potentiate the 
differentiation of osteoprogenitor cells and may have also enhanced bone formation 
(Klokkevold et al, 1996).  In a study using methylpyrrolidinone chitosan in an animal 
model of a bone defect, Muzzarelli et al (1993) found that the cationic nature and 
chelating ability of this chitosan favored mineralization of neoformed bone tissue, while 
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control defects showed only minimal bone formation originating only from pre-existing 
bone or from the periosteum (Muzzarelli et al, 1993).   
Studies exploring the use of chitosan to potentiate neochondrogenesis have shown 
similar trends, such as the ability of chitosan to promote the maintenance of the 
chondrocyte phenotype and biosynthesis of extracellular matrix components, 
glycosaminoglycans and type II collagen, when grown on two-dimensional substrates of 
chitosan (Lahiji et al, 2000) or chitosan hydrogels (Sechriest et al, 1999).                 
 
Potential Advantages of Chitosan to Synthetic Polymers 
 Chitosan may have certain advantages over the more widely studied synthetic 
polymers used in cartilage tissue engineering applications.  One advantage may be the 
relatively easy preparation of chitosan substrates.  Chitosan powder is soluble in mildly 
acidic solutions, below pH 6.5, except in solutions containing sulfuric acid or phosphoric 
acid, and is most commonly dissolved in formic acid or acetic acid.  Once dissolved, 
chitosan solutions can be either centrifuged or filtered to remove any undissolved 
particles, after which it can be easily formed into bulk porous scaffolds through a simple 
freezing and lyophilization process.  Ice crystals that nucleate during freezing are 
removed from the frozen solutions by lyophilization, which creates an interconnecting, 
porous matrix.  Furthermore, there is evidence that microstructural properties of porous 
scaffolds can be controlled by varying the chitosan concentration, molecular weight, 
percent deacetylation, degree of crystallinity, and the rate of freezing of the solution.  For 
example, the pores become larger as the rate of freezing decrease (Madihally and 
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Matthew, 1999).  Chitosan crystallinity can be controlled by reacting dissolved chitosan 
with aqueous, dilute nitrous acid, which depolymerizes chitosan chains by reacting with 
amino groups and cleaving the polymer at the -glycosidic lingages.  The rate of this 
depolymerization reaction was found to be independent of molecular weight (Allen and 
Payron, 1995).  Controlling the crystallinity of chitosan may provide another means by 
which to control the microstructural properties of porous chitosan scaffolds and the rate 
at which they degrade.  Furthermore, chitosan’s free hydroxyl and amino groups provide 
an easy means of derivitization of this polymer and easy attachment of other bioactive 
side groups.  
 Processing procedures involved in creating synthetic polymer matrices for tissue 
engineering often include time, labor, and money intensive methods whose results are not 
always reproducible.  Synthetic polymer processing can also involve the extensive use of 
toxic solvents.  In the case of solvent casting used to prepare thin membranes, results are 
often less than desirable with respect to pore interconnectivity and can only be used to 
produce very thin membranes.  Other processes including emulsion freeze-drying and 
thermally induced phase separation technology are very dependent upon the user and the 
technique employed.  Emulsion freeze-drying is a process by which an emulsion, which 
consists of small monomer particles (0.05 - 0.5 m) surrounded by a surfactant in water 
to which an initiator is introduced to start the polymerization process.  The end product is 
a stable latex in water, which is freeze dried to recover the polymer (Tadmor and Gogos, 
1979).  Thermally induced phase separation technology involves using a latent solvent , 
one that is a high-boiling, low molecular weight solvent for the polymer at hight 
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temperatures, but a nonsolvent at lower temperatures, to cool a polymer mixture to a 
point of thermal separation.  At this point the solvent phase can be extracted to recover 
the polymer phase (Fried, 1995). 
Though some groups have been very successful in precisely controlling the 
properties of their polymers by using rapid prototyping and fused depositing modeling 
techniques, these are also extremely time consuming and expensive (Hutmacher, 2000).  
Therefore, the simplicity involved in producing chitosan matrices helps make it an 
attractive alternative to synthetic polymers used in tissue engineering.   
Chitosan matrices also display strong cell adhesion properties without further 
processing, due to its cationic nature and high charge density.  Often times, synthetic 
polymers require the blending of two or more polymer types, such as poly-L-lactide 
(PLLA) and poly (D,L-lactide co-glycolide) (PLGA) to induce optimal cell adhesion 
(Cohen et al, 1993).  Furthermore, given that the chemical structure of chitosan is similar 
to that of glycosaminoglycans and hyaluronic acid, which have been implicated as 
important stimulators of chondrogenesis, chitosan may also share this and other 
characteristics with these molecules.  Chitosan is also able to form insoluble ionic 
complexes with these molecules, which may aid in the integration of chitosan implants 
with native tissues (Suh and Matthew, 2000).  In light of these promising characteristics 
of chitosan, the present research is aimed at an initial investigation of using three-





Statement of Hypotheses 
The primary hypothesis was that the simple freezing and lyophilization of a 
chitosan-acid solution would produce bulk chitosan matrices possessing an 
interconnecting porous structure.  To test this hypothesis chitosan scaffolds were 
fabricated through the simple freezing and lyophilization of a chitosan-acid solution.  
Chitosan-acid solutions were analyzed for viscosity, and completed scaffolds were 
analyzed by mercury intrusion porosimetry (MIP), scanning electron microscopy (SEM), 
mechanical compression, and in degradation tests to determine optimal conditions for 
producing these matrices.  The secondary hypothesis was that porous chitosan scaffolds 
would support neochondrogenesis (i.e. the synthesis of a cartilaginous matrix by 
chondrocytes) in vitro.  This entailed evaluations of chondrocyte attachment, viability, 









 To address the first hypothesis, chitosan scaffolds fabricated for cartilage tissue 
engineering must be highly porous and degrade at a rate consistent with the rate of new 
tissue formation.  The goal was to produce degradable scaffolds with a target overall 
porosity between 90%-95%, consisting of pores with an average diameter between 100-
300 m.  In an effort to find the best process for creating such scaffolds, parameters 
including the acid used as the solvent for the chitosan powder, the size and shape of the 
container used to freeze the solutions, and the rate of freezing of the solutions were 
varied.  The viscosities and pH’s of these solutions were also determined and compared.  
Solutions were frozen in either 35mm petri dishes or plastic vials and lyophilized to form 
bulk, porous scaffolds.  Once lyophilized, chitosan scaffolds were analyzed for surface 
morphology by scanning electron microscopy (SEM).  Scaffolds were scanned and 
evaluated for surface pore size and the appearance of an interconnecting pore structure.  
Scaffolds were also analyzed in two-dimensional sections after being embedded, 
sectioned, stained and photographed under a bright field microscope.  The images were 
then digitized and evaluated for pore fraction, average pore diameter, and overall two-
dimensional porosity.   
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Representative scaffolds were sent to Micrometertics, Norcross, GA, for three-
dimensional evaluation by mercury intrusion porosimetry.   
An additional ten scaffolds having a thickness of 6.35 mm and diameter of 12.7 
mm, underwent mechanical evaluation.  These scaffolds were assessed using a stress 
relaxation test to determine an equilibrium compression modulus.    
Finally, scaffold degradation was analyzed.  Methods were adapted from ASTM 
F-1635-95, Standard Test Method for Testing the In Vitro Degradation of Poly (L-lactic 
Acid) Resin and Fabricated Form for Surgical Implants.  Eight test scaffolds were 
incubated in complete culture medium containing 500 g/ml chick egg white lysozyme, 
while eight control scaffolds were incubated with complete culture medium only.  Test 
and control scaffolds were divided into four groups corresponding to four time periods of 
incubation in test and control solutions.  The dry weights of the scaffolds were measured 
before the beginning of the incubation period, and the dry weights of two test and two 
control scaffolds were measured at one, four, seven, and fourteen days following the start 
of the test.  Scaffolds were 5 mm in diameter  2mm thick (0.0125 cm2).  Two milliliters 
of solution was used for each scaffold, which yielded a ratio of solution volume to 
scaffold surface area of 160:1.  A ratio of at least 100:1 is suggested by the standard.   
  To address the second hypothesis ten chitosan scaffolds (5 mm in diameter  
2mm thick) were seeded with porcine chondrocytes from three-week old pigs (5  105 
cells/ml) and cultured in a 50 ml rotary bioreactor vessel for up to 28 days.  After 48 
hours, two scaffolds were harvested, and analyzed for cell attachment using SEM or 
viability using the LIVE/DEAD cell viability/cytotoxicity assay (LIVE/DEAD Cell 
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Viability/Cytotoxity kit, Molecular Probes, Eugene, OR).  After one, two, three, and four 
weeks, two of the remaining scaffolds were harvested, fixed, embedded, and analyzed for 
the presence of proteoglycan and type II collagen-rich ECM by histological and 
immunohistochemical methods. 
  In a later test, three 5 mm diameter  2mm thick scaffolds were seeded with three-
week porcine chondrocytes (16  106 cells/ml) and cultured in a 10 ml rotary bioreactor 
vessel.  All three scaffolds remained in culture for the 28-day period and were then 
analyzed as described earlier. 
 
Experimental Methods 
Scaffold Fabrication and Analysis 
To begin, 86% deacetylated, powdered chitosan with a molecular weight of 
200,000 g/mol (Vanson, Inc., Redmond, WA) was dissolved in 0.2 M acetic acid and 1% 
solutions of acetic, formic, and propionic by stirring for 48 hours.  Once dissolved, the 
pH of each solution was tested with a pH meter, and their viscosities were tested using a 
Brookfield viscometer.  The #2 spindle was used to test the solutions at motor speeds 
ranging from 5 to 30 rpm.  Viscosities were then plotted as a function of shear rate to 
evaluate the validity of comparing the viscosities of the different solutions to one another 
within this range of shear rates.   
Chitosan-acid solutions were poured into 35mm polystyrene petri dishes to a 
depth of approximately 5 mm and frozen at -27C or into 12.7 mm diameter plastic vials 
to a final volume of 7 ml and frozen at -9C.  The solutions were allowed to freeze for 48 
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hours.  Solutions in 35 mm petri dishes were then moved to a -80C freezer where they 
were kept until lyophilization.  The frozen chitosan cores from the plastic vials were 
removed from the vials by inversion after brief submersion in a 37C water bath before 
being moved to the -80C freezer.  Frozen solutions were then lyophilized at -40C for 24 
hours or until completely dry.  Lyophilization of scaffolds causes the removal of ice 
crystals from the frozen solutions, which produces the interconnecting, porous structure 
of the scaffolds.  
To evaluate the time needed to freeze chitosan solutions, a thermocouple was 
inserted into one of the solutions frozen in a 35 mm petri dish during the freezing 
process.  Temperatures were recorded every 10 minutes and a graph was constructed of 
temperature versus time using the collected data. 
 
Microstructural Characterization  
Lyophilized scaffolds were evaluated for surface morphology by examination 
under SEM, for three-dimensional microstructural properties using mercury intrusion 
porosimetry (MIP), and for two-dimensional properties using embedding, staining, and 
imaging techniques. 
To analyze the surface characteristics of lyophilized scaffolds using SEM, they 
were first mounted on specimen holders with carbon tape and then sputter-coated with 
gold palladium to make them conductive.  One three-minute coating was sufficient to 
eliminate charging inside the scope.  Specimens were then simply placed in the SEM 
scope and visualized using secondary electron detection mode.   
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One scaffold from each fabrication technique was sent for three-dimensional 
evaluation by MIP on an Autopore IV 9500 (Micromeritics, Norcross, GA).  MIP is 
based on the premise that a non-wetting liquid, such as mercury, will only intrude pores 
under pressure.  Pore diameter is calculated according to the Washburn equation 
(Washburn, 1921): 
p = (-4cos)/d 
Where p is the pressure required to force mercury into a pore of entry diameter d,  is the 
mercury surface tension, and  is the contact angle between mercury and the sample.  The 
contact angle of mercury on chitosan is 130 degrees, and mercury surface tension is 485 
dynes/cm.  A total of 266 low- and high-pressure data points in the range of 1.2 kPa to 
413.7 MPa are collected to provide a high-resolution profile of mercury uptake. 
Scaffolds from each fabrication technique were embedded in glycolmethacrylate 
(Immunobed, Polysciences, Niles, IL), sectioned to 7 m using a rotary microtome, and 
mounted on slides to be stained and evaluated in two-dimensions.  Chitosan’s 
polycationic nature allows it to absorb anionic dyes, such as eosin, which was used to 
highlight the chitosan on the sections.  Sections were mounted with glass coverslips using 
Permount (Fisher Scientific, Fair Lawn, NJ) and photographed with bright-field 
microscopy.  Once digitized, the images of sections were analyzed using NIH Image for 
overall porosity and pore diameter.  The results from two-dimensional and three-






Ten scaffolds from each fabrication technique having a thickness of 6.35 mm 
were mechanically tested in compression.  These scaffolds were fully rehydrated before 
being tested.  They were compressed in 5% increments to 50% of their initial height 
using the fixture shown in figure 3.  It consists of a micrometer head connected in series 
with a  50 N load cell.  The micrometer head was used to precisely control each step of 
compression.  Scaffolds were held at each step for five minutes and then compressed to 
the next strain level.  Stress relaxation was monitored and recorded using LabVIEW 
software.  The data were then used to compute an equilibrium compressive modulus for 
each type of chitosan scaffold tested. 
 
Micrometer Head 
 50 N Load Cell
Chitosan Sample 
 
Figure 3.  Mechanical Testing Fixture Used to Compress Chitosan Scaffolds 
 
Degradation  
To assess degradation of chitosan scaffolds in vitro, eight fully rehydrated 
scaffolds were incubated in 2 ml of complete culture medium containing 500 ug/ml chick 
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egg white lysozyme.  This concentration of lysozyme was chosen in order to produce an 
effect, and is not necessarily the concentration present in vivo.  Eight control scaffolds 
were incubated in complete culture medium without lysozyme.  Incubations were done in 
a 37C humidified 5% carbon dioxide (CO2) incubator throughout the two-week study.  
The dry weight of each scaffold was determined before incubation.  The dry weights of 
two control and two test scaffolds were measured again after one, four, seven and 
fourteen days of incubation.  Scaffolds were dehydrated in a graded ethanol series before 
being measured.   Scaffold weights were then recorded and compared to their initial dry 
weight.  Degradation was determined as the percentage of weight loss as described by 
Section 8 of ASTM F-1635, and according to the formula: 
% WL =[(W0 – W)/W0]*100, 
where WL was weight loss, W0 was initial weight, and W was weight after degradation.  
Statistical significance for main effects was determined using a two way ANOVA at the 
95% confidence level, and treatment effects were determined using Tukey’s honestly 
significantly different test also at the 95% confidence level. 
 
Solutions Viscosities 
 The viscosities of chitosan-acid solutions were tested using a Brookfield 
Viscometer.  The #2 spindle was used to test the solutions at motor speeds ranging from 5 
to 30 rpm.  Viscosities were then plotted as a function of shear rate to evaluate the 
validity of comparing the viscosities of the different solutions to one another within this 
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range of shear rates.  Statistical significance was determined for the viscosities using a 
one way ANOVA at the 95% confidence level. 
 
Cell Isolation and Culture 
Initially, ten scaffolds were prepared for cell culture.  They were partially 
rehydrated in a graded ethanol series (100%, 95%, 80%, 70%) to a 70% ethanol solution 
at which time they were cored using a 5 mm diameter core punch.  These cores were then 
added to a fresh 70% ethanol solution and remained there overnight.  This 24-hour 
incubation facilitated scaffold being bacteriostatic.  After this 24 hour incubation, 
rehydration was completed with a solution of 50% ethanol to a final solution of 
phosphate buffered saline (PBS) containing 2 antibiotics-antimycotics.  The scaffolds 
were incubated for at least 24 in this PBS solution to help ensure sterility.  Before being 
seeded with cells, scaffolds were incubated with sterile fetal bovine serum (FBS) for 
twenty-four hours to coat the scaffolds with cell-essential proteins and facilitate cell 
attachment. 
 Chondrocytes were isolated from native cartilage harvested from the femoral 
chondyles of three-week-old pigs, using aseptic technique.  Cartilage was minced with a 
scalpel, and the pieces were incubated with 1% type 2 collagenase dissolved in a 5% fetal 
calf serum solution in Dulbecco’s Modified Eagles Medium (DMEM) and stirred 
overnight.  This enzymatic solution digested the cartilaginous matrix components, 
releasing the cells into the medium.  The solution was filtered through a 100 m sterile 
filter and subsequently centrifuged at 1000 rpm for eight minutes to produce a cell pellet.  
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After the medium was removed from the pellet, the cells were resuspended at 5  105 
cells/ml in complete cell culture medium (DMEM, 1% L-glutamine, 1% antibiotic-
antimycotic, 10% FBS, and 50 ng/ml ascorbate) in a 50 ml rotating-wall bioreactor vessel 
(Synthecon, Houston, TX).  The chitosan scaffolds were added to the vessel, where they 
remained in culture with the chondrocytes for up to 28 days.  Cultures were kept in a 
37C humidified CO2 incubator.   
The rotating-wall bioreactor vessel system has been shown to be the optimal 
method of culturing three-dimensional cartilage constructs.  Freed and Vunjak-
Novakovic, 1995, showed that when rotating such that constructs are in a state of 
constant freefall, that bioreactor culture conditions most closely mimic in vivo 
chondrogenesis conditions (Freed and Vunjak-Novakovic, 1995).  They also showed that 
this method of culture helps modulate the composition and mechanical properties of 
tissue engineered cartilage.  Vunjak-Novakovic et al, 1998, found that cartilage 
constructs cultured in microgravity (in free-fall in a bioreactor) resulted in the highest 
fractions of regenerated tissue and glycosaminoglycans (GAG), when compared to 
constructs grown in other culture conditions including orbital mixing cultures, solid-body 
rotation, and spinner-flask culture.  This environment also helps promote the maintenance 
of the chondrocyte phenotype throughout extended culture times (Freed and Vunjak-
Novakovic, 1997).   
The speed of our bioreactor was adjusted to 17.5 rpm, which allowed constructs 
to stay in a state of constant free-fall throughout the duration of the study.  As scaffolds 
rotated in this low shear environment, nutrients were able to reach cells that have 
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attached to the interior of the scaffolds, and at the same time, metabolic waste products 
were moved away from the cells and out into the medium.  In other words, this 
environment allows efficient mass transfer.  The medium was changed every three days, 
at which time, the cultures were supplemented with L-ascorbic acid to a final 
concentration of 50 ng/ml.  L-ascorbic acid is necessary for cartilaginous matrix 
synthesis. 
Another trial was performed with three scaffolds fabricated using 1% formic acid 
as the solvent.  These scaffolds were chosen based on results from the degradation study.  
Because higher initial cell density has been shown to increase the quantity and quality of 
engineered cartilage (Puelacher et al, 1994), this trial was performed with an initial cell 
density of 16 million cells/ml of culture medium.  Scaffolds were seeded in a 10 ml 
culture vessel and after 24 hours were moved to a 50 ml culture vessel at which point 20 
million more cells were added.  In this trial, all scaffolds remained in culture for four 
weeks. 
 
Cell Attachment and Viability 
 Cell attachment was evaluated after 48 hours for the first trial, by performing a 
hemocytometer count of cells remaining in the medium.  The number counted was 
subtracted from the initial cell density to determine the number attached to each scaffold.  
One scaffold from the first trial was also fixed in 2.5% glutaraldehyde, dehydrated in a 
graded ethanol series, and chemically dried with Hexamethyldisilazane (HMDS) for 
viewing by SEM.  This construct was mounted with carbon tape on a specimen holder 
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and sputter-coated with gold-palladium to render it conductive.  Two, three minute 
coatings was necessary to prevent charging in the scope.   The specimen was viewed in 
secondary electron detection mode on a LEO Stereoscan 360 (MSU Electron Microcopy 
Center) and its surface evaluated visually for cell attachment.   
Cell viability was also evaluated after the 48 hour seeding period for the first trial 
and was confirmed by intracellular esterase activity as indicated by the green 
fluorescence of calcein that is enzymatically converted from calcein AM in live cells. 
Dead cells were simultaneously recognized by their red fluorescence, due to the binding 
of nucleic acids to ethidium homodimer-1 that enters the cells through damaged 
membranes.  Samples were viewed qualitatively on a LEICA TSNSC Confocal Laser 
Scanning Microsope (MSU Electron Microsopy Center).  The 48 hour cell attachment 
and viability analyses were not performed on scaffolds from the second trial because the 
scaffolds were moved to the larger volume vessel after 24 hours.  Also there were only 
three scaffolds, which were all needed at the 4-week end point for other analyses.   
 
Histology and Immunohistochemistry 
The remaining scaffolds in the first trial were maintained in culture for 10, 18, and 
28 days.  All scaffolds from the second trial were harvested after 28 days.  Scaffolds from 
first trial were processed for either histology or immunohistochemistry, while scaffolds 
from the second trial were processed only for histology.  All samples were fixed in 
Carnoy’s solution, which is a 3:1 solution of 95% ethanol to glacial acetic acid.  This 
fixative was recommended by the Developmental Hybridoma Bank, Iowa City, Iowa, for 
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use with the II-II6B3 anti-type II collagen antibody, which was used for 
immunohistochemical procedures.  After at least two hours in the fixative, samples were 
washed extensively with 95% ethanol to eliminate residual acid, and were then washed 
several times in 100% ethanol to complete dehydration.  Samples were cut in half and 
were embedded in glycolmethacrylate (Immunobed, Polysciences, Niles, IL) in a vacuum 
chamber.   
For routine histology, glycolmethacrylate blocks containing samples were 
mounted in the specimen holder of a rotary microtome and sectioned to 7 m.  Sections 
were placed on charged glass slides and allowed to dry for 24 hours.  Sections were 
stained with hematoxylin and eosin and counter stained with toluidine blue to highlight 
proteoglycan-rich ECM (Kiernan, 2000).  Slides were subsequently dehydrated, cleared 
in xylenes, and mounted with glass coverslips using Permount.  Using this staining 
technique, cell nuclei stain blue, and areas of ECM that contain proteoglycans stain 
metachromatically.   
Samples that were to be analyzed immunohistochemically for type II collagen, 
using a HistoStain SP Kit (Zymed, San Francisco, CA) were cut to 8 m.  After being 
placed on charged slides and allowed to dry, sections were rehydrated in a graded ethanol 
series to PBS and incubated with 2500IU/ml hyaluronidase (H6254, Sigma, St. Louis, 
MO) for 5 minutes.  This enzyme digests any hyaluronic acid in the extracellular matrix 
that may be blocking antigenic-binding sites.  After washing in PBS, section were 
incubated for 10 min with a peroxidase solution (1 part 30% hydrogen peroxide to 9 parts 
100% methanol) and washed in PBS (5  5 min).  Sections were then incubated with 10% 
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non-immune goat serum to block non-specific antigen binding sites.  At this point, the 
blocking solution remained on negative control sections, while experimental sections 
were incubated for 120 min with a monoclonal antibody to type II collagen in a 37C 
humidified CO2 incubator.  After another 5  5 min washing in PBS, all sections were 
incubated for 30 min with a biotinylated secondary antibody at 37C and subsequently 
washed.  Sections were then incubated for 30 min with a streptavidin-peroxidase 
conjugate, 10 min with a substrate-chromagen (hydrogen peroxide-DAB) mixture, and 
rinsed for 2 min with distilled water.  Finally, sections were stained for 3 min with 
hematoxylin, and underwent a final rinsing for 30 sec in PBS and 2 min in distilled water.  
The sections were then dehydrated in a graded ethanol series, cleared in Xylene, and 
mounted with glass coverslips using Histomount (Zymed Laboratories, San Francisco, 
CA).  Areas where type II collagen was present on experimental sections stain orange-














Scaffold Fabrication and Analysis 
 Bulk, porous chitosan scaffolds were easily fabricated using a simple freezing and 
lyophilization process.  Scaffolds fabricated by dissolving 86% deacetylated chitosan 
powder in 0.2 M acetic acid and freezing in 35 mm petri dishes at –20C, revealed a what 
appeared to be an interconnecting porous structure when viewed under SEM (Figure 4A); 
however, when visually insepected, scaffold surfaces that had been in contact with 
polystyrene, displayed a very different surface structure that was less porous than 
scaffolds surfaces that did not contact petri dish surfaces (Figure 4B).  Upon visual 
inspection of SEM microphotographs of scaffolds fabricated by dissolving 86% 
deacetylated chitosan powder in 0.2 M acetic acid and subsequently freezing in 12.7 mm 
diameter vials at –9C, appeared to possess a more porous structure than scaffolds frozen 
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Figure 4 A. 100X SEM of Porous Chitosan Scaffold Surface  B. 100X SEM of Porous 





Figure 5.  100X SEM of Porous Chitosan Scaffold Frozen in Plastic Vial at –9 C 
 
 Figure 6 represents that temperature verses time data for the freezing of chitosan 
solutions in 35 mm petri dishes in a -27C freezer.  The temperature of the solutions 
dropped in a parabolic fashion until the solution reached 0C, at which point the 
temperature remained constant until the entire volume of solution was frozen.  The 
temperature then began to decrease further to reach the temperature of the freezer.  The 
time taken from the solutions to reach equilibrium at 0C was approximately 2 hours and 





















Figure 6.  Temperature Vs. Time for Freezing of Chitosan Solutions in 35 mm Petri  
Dishes at -27C 
 
Microstructural Characterization 
Three-dimensional microstructural properties, as determined by MIP analysis, for 
one scaffold made by freezing in a 35 mm petri dish and one scaffold made by freezing in 
a 12.7 mm vial is shown in Table 1.  Both scaffolds were made using acetic acid as the 
solvent. 
Table 1.  Scaffold Properties Determined Using MIP 
Freezing Container Bulk Density Total Pore Area Total Porosity 
35 mm petri dish 0.06 g/ml 0.8 m2/g 80.70% 





The overall porosity of the scaffold frozen in the 12.7 mm plastic vial was 94%, 
while the overall porosity of the scaffold frozen in the 35 mm plastic petri dish was only 
80%.  By visual inspection, scaffolds frozen in vials appeared to have much larger pores 
in interior regions (the region used for cell culture), while those pores closer to the 
exterior where much smaller.  Note, only one scaffold of each type was sent for analysis 
because of cost constraints; hence, the lack of statistical analysis. 
   
Mechanical Testing 
 The compressive modulus of porous chitosan scaffolds frozen in 35mm 
polystyrene petri dishes was found to be 3.5  0.4 kPa in the 50% compression range.  
While this is similar to the compressive modulus of other common culture mediums such 
as alginate or agarose, it is much softer than healthy hyaline cartilage, which has a 
compressive modulus of 1 MPa in healthy individuals (Mow et al, 1991).  Figure 7 shows 
the stress vs. strain curves for three porous chitosan scaffolds that were representative of 




Figure 7.  Engineering Stress Vs. Strain Curve for Chitosan Scaffolds 
 
Solution Viscosities 
 The viscosities of chitosan-acid solutions were determined to be Newtonian, as 
determined by their plots of viscosity versus shear stress being linear (Figure 8).  In this 
plot, viscosity does not change significantly as shear stress increases for any solution.  
Figure 9 compares shear rate versus shear stress for three different solutions.  Because 
solutions viscosities were not determined to be significantly different from one another 
(p-value > 0.05), this property was determined not to be an indicator of degradation rate 




















































 Upon visual inspection of scaffolds exposed to lysozyme for four days, it was 
evident that formic acid scaffolds degraded most quickly, followed by propionic acid 
scaffolds.  Acetic acid scaffolds did not appear to have degraded at all and looked similar 
to control scaffolds at this time point (Figure 10).  
 
 
Figure 10.  Acetic Acid (A), Propionic Acid (P), and Acetic Acid Control Scaffolds (C)  
After 4 Days 
 
 
 Scaffolds incubated with lysozyme degraded significantly faster than control 
scaffolds (p-value > 0.05).  Formic acid scaffolds were determined to degrade 
significantly faster than both propionic acid scaffolds and acetic acid scaffolds, while 
there was no significant difference between the rate of degradation of propionic acid 
scaffolds and acetic acid scaffolds.  Figure 11 shows the means plot for the mean weight 
loss with respect to acid type of the scaffolds.  The asterisks represent significant 





























Figure 11.  Means Plot for Weight Loss Vs. Acid Type (P = Propionic Acid Scaffolds,  
A = Acetic Acid Scaffolds, F = Formic Acid Scaffolds) 
 
 
Cell Attachment and Viability 
From the hemocytometer count of unattached cells from the first cell culture trial, 
it was determined that 2.5  105 cells attached to each of 10 scaffolds after 48 hours.  
SEM microphotographs showed a fairly uniform covering of cells on the scaffold surface 
(Figure 12A) and the maintenance of the spherical morphology characteristic of a 
chondrocyte by attached cells (Figure 12B).  The cell viability assay also showed a fairly 
uniform covering of cells on the scaffold and a large number of viable cells.  Though 
some dead cells were visible, though some dead cells were visible, it was difficult to 
estimate their numbers due to the chitosan displaying the same red color as the dead cells.   
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Figure 12 A.  100X SEM Micrograph of Cells Attached to Chitosan Scaffolds After 48 
Hours  B.  1500X SEM Micrograph Showing the Spherical Morphology of 
Cells Attached to Chitosan Scaffolds After 48 Hours 
 
 
Histology and Immunohistochemistry  
 Histological sections from day 18 scaffolds from trial one showed that cells were 
attached to the chitosan and had begun to fill pores.  Some cell-dense areas stained 
metachromatically with toluidine blue, indicating the presence of proteoglycan-rich ECM 
(Figure 13A and B).  These biosynthetic phenomena were mostly confined to the 
periphery of the scaffolds because those cells on the exterior of the scaffolds tended to 
form a “shell” and effectively starved any cells that had attached or migrated to the 
interior of the scaffolds.  It was also evident from histological sections than some closed 
pore volume existed within the scaffold microstructure preventing cells from attaching to 
all interior surfaces.  Scaffolds from 28 days showed similar trends (Figure 14A).   
Histological sections from 28 day scaffolds from the second trial revealed a larger 
number of cells in interior pores of the scaffolds.  These cells as well as those closer to 
the exterior of the scaffolds did produce proteoglycan-rich ECM, which is highlighted by 
the metachromatic staining shown in figure 14B.  These histological sections both 
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imaged at 40X were also used to compare the microstructures of the scaffolds at the 28 
day time point.  The microstructure of the scaffold shown in figure 14A and used in the 
first trial was clearly denser than that of the scaffold shown in figure 14B, used in the 
second trial.   
The cell clusters that displayed methachromasia with toluidine blue from the first 
trial were the same areas that stained positively (orange-brown) for type II collagen 
(Figure 15 A and B).  Most collagen synthesis appeared to be pericellular, or confined to 
those regions immediately adjacent to cells.  Constructs analyzed after 28 days showed 
similar trends. 
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Figure 13A. And B. Histology Sections from Day 18 Scaffolds Stained for Proteoglycans  
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Figure 15A. and B.  Immunohistochemical Histology Sections from Day 18 Scaffolds 





SUMMARY AND DISCUSSION 
Summary 
Chitosan scaffolds possessing an interconnecting porous structure were easily 
fabricated using a simple freezing and lyophilization process.  The scaffolds that resulted 
from freezing chitosan solutions in 35mm petri dishes at –20C appeared to limit scaffold 
performance because of their low porosity.  This problem was addressed by altering 
scaffold fabrication parameters including the shape and size of the container used to 
freeze the solutions and the temperature at which the solutions were frozen.  By freezing 
the chitosan in cylindrical vials at –9C, porosity was increased to 94%; however, results 
from MIP suggest that the average pore diameter was smaller in these scaffolds.  It is 
believed that this was due to the average pore diameter being an average of all pores and 
not just those contained within the area used for culture, which were cut from the center 
most portion of the larger cylindrical chitosan plugs.  Visually, pores in this area were 
obviously larger than those in the areas not used in culture and larger than those in 
scaffolds frozen in 35 mm petri dishes at –20C. 
Scaffolds showed minimal mechanical integrity before cells were added to them, 
but were strong enough to support cell attachment and growth and remained in tact 
through the culture period in the rotating bioreactor.  
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Scaffold performance was also measured by their ability to biodegrade during the 
28-day culture period.  Degradation tests conducted in the absence of cells suggested that 
scaffolds fabricated using formic acid as the solvent would degrade an average of 67% 
faster than their acetic acid counterparts.  This may lead one to believe that acetic acid 
may somehow inhibit the action of the lysozyme, the enzyme responsible for breaking 
down chitosan, while formic acid may not.  It is possible that perhaps acid salts remained 
in the scaffold microstructure after volatile acid was removed during lyophilization.  This 
suggests than a relationship may exist between these salts and the lysozyme’s ability to 
attack key complexes in the chitosan structure.  This proposed relationship between the 
acid salts and lysozyme should be investigated further before any strong conclusions are 
drawn concerning lysozyme inhibition.  It should also be noted that when used in culture 
both scaffold types remained largely unchanged.   
In terms of their ability to truly organize the cells in three dimensions, the more 
porous scaffolds were more successful.  When cultured on the less porous scaffolds, large 
numbers of cells were unable to penetrate to the interior of the scaffolds, and those that 
did, appeared to be effectively starved by cells forming a shell around the exterior of the 
scaffolds.  When more porous scaffolds were used in culture, cells were able to 
penetrated further into the scaffold microstructure; however, this may have been due in 
part to the higher cell seeding density.  Both scaffold types were judged equally as 
capable of supporting the biosynthesis of a proteoglycan and type II collagen-rich 





 It appeared that by changing the morphology of the freezing container and the rate 
at which solutions were frozen, that porosity was fairly easily altered.  It would be useful 
to know exactly how changing each parameter affected the porosity.  Using the 
thermocouple to monitor the freezing rates of solutions over a range of temperatures 
would be one way of answering at least the question of how temperature affects the 
porosity.  However, perhaps a more versatile method would be to create a finite element 
model of the system in which one would have more freedom in varying parameters and 
would be able to visualize the effects more quickly.   
Perhaps other parameters such as crystallinity of the chitosan solutions and the 
physical state of the solutions before freezing are also responsible for not only affecting 
final porosity, but also affecting degradation rate and overall scaffold performance.  With 
this in mind, current research is being conducted using Nuclear Magnetic Resonance to 
determine exactly what is present in chitosan solutions made with different acids.  This 
information may be useful in determining what inhibits or enhances degradation of 
scaffolds.  Solutions are also being cast as films for viewing under a polarizing light 
microscope to determine the crystallinity of solutions, as crystallinity may play a role in 
porosity and degradation rate.  There has also been some evidence that by allowing a 
chitosan solution to gel before freezing may have an effect on porosity.  Tests to evaluate 
this theory are currently being conducted.   
Still another avenue being investigated is the attachment of side groups to the 
chitosan structure using available amino groups as reactive sites.  Possibilities for 
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attachment include proteins that may enhance chondrogenesis, or other inert groups that 
may serve to help control or predict the rate of degradation of the polymer during culture.  
By further understanding the chemistry responsible for the scaffold’s physical properties 
and performance, both chemically and in-culture, it may be possible to create specially 
tailored chitosan scaffolds for specific applications.  
 Chitosan is a biopolymer with many promising characteristics including its 
antimicrobial activity, its ability to bind cells and sustain their life, and the availability of 
reactive groups for modifying its structure.  Chitosan may prove to be a useful 
biomaterial for applications other than tissue engineering, as is currently being 
investigated by others, including applications in artificial skin, nerves, would healing, 
biological coatings, and drug delivery.  The present research showed chitosans usefulness 
for cartilage tissue engineering, and also began to show its versatility by discovering the 
ease with which this material can be manipulated to fit certain circumstances.  Given that 
chitosan is an abundant waste product of the shellfish industry, is relatively inexpensive 
to researchers, and is fairly easily processed, this polymer should be further investigated 
for wide use as a biopolymer in medical applications and may provide a useful and less 
expensive alternative to conventional materials currently being used.    
Conclusions 
This discovery-based research has opened several avenues of thought concerning 
chitosan as a biopolymer for tissue engineering applications.  In this work, two different 
chitosan scaffold types were generated that were able to support the attachment and 
viability of chondrocytes, and help to maintain their spherical morphology characteristic 
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of the chondrocyte phenotype.  Cells attached to both types of scaffolds also showed a 
biosynthetic profile including proteoglycans and type-II collagen.  However, scaffolds 
frozen at a slower rate, and therefore possessing greater total porosity, supported this 
activity through a greater volume than scaffolds frozen more quickly and possessing a 
denser microstructure.  Through both trials, scaffold microstructure and degradation 
characteristics seemed to be the limiting factors.  Though scaffolds frozen at a slower rate 
were more porous, it is possible that both scaffold types possess a certain amount of 
closed pore volume that prevents complete penetration of cells into all void areas; 
however, results were promising and did indicate that given optimal chitosan scaffolds, 
that this polymer might prove to be a useful alternative to synthetic polymers in cartilage 
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